RareCan
RareCan is an organisation for the purpose of speeding up research and ultimately improving outcomes for people with rarer forms of cancer.
RareCan is a business in biotechnology, clinical trials, health care, medical, founded in 2019.
The company sits in the biotechnology, clinical trials, health care, medical segment, where it competes on its core product or service.
Directory data places it at the Equity_Crowdfunding stage.
Recorded headcount: c_00011_00050 employees.
It has disclosed roughly $577K in funding.
| Sector | Biotechnology, Clinical Trials, Health Care, Medical |
|---|---|
| Founded | 2019 |
| Employees | c_00011_00050 |
| Stage | equity_crowdfunding |
| Total funding | $576,877 |
Website: www.rarecan.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account